Szoliter hasnyálmirigy-átültetés elso esete Magyarországon

Translated title of the contribution: The first case of single pancreas transplantation in Hungary

Péter Szakály, Nágy Károly Kalmár, I. Wittmann

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Simultaneous pancreas kidney (SPK) transplantation is the only routinely used therapeutic option which can provide insulin independence, euglycemia and good renal replacement for type I diabetes mellitus patients with end stage renal disease. Several patients have some complications of diabetes without renal failure. For these patients pancreas transplantation alone is a therapeutic option. The first pancreas transplantation alone was performed 6 years after the launch of our pancreas transplant program. The patient was a 40-years-old man. Enteric drainage was used with portal venous drainage. Anti IL-2. R antibody, daclizumab was given as prolonged induction therapy. In spite of the technical and immunological difficulties there were neither technical failures nor acute rejection. 3 years after the transplantation the patient has a good quality of life without insulin therapy with excellent renal function. Conclusion: PTA transplant is a routinely used therapeutic option with good survival rate and good quality of life for type I diabetes mellitus patients without end stage renal disease.

Original languageHungarian
Pages (from-to)387-391
Number of pages5
JournalOrvosi Hetilap
Volume149
Issue number9
DOIs
Publication statusPublished - Mar 2 2008

Fingerprint

Pancreas Transplantation
Hungary
Type 1 Diabetes Mellitus
Chronic Kidney Failure
Drainage
Quality of Life
Insulin
Transplants
Kidney
Therapeutics
Diabetes Complications
Kidney Transplantation
Interleukin-2
Renal Insufficiency
Pancreas
Survival Rate
Transplantation
Antibodies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Szoliter hasnyálmirigy-átültetés elso esete Magyarországon. / Szakály, Péter; Kalmár, Nágy Károly; Wittmann, I.

In: Orvosi Hetilap, Vol. 149, No. 9, 02.03.2008, p. 387-391.

Research output: Contribution to journalArticle

Szakály, Péter ; Kalmár, Nágy Károly ; Wittmann, I. / Szoliter hasnyálmirigy-átültetés elso esete Magyarországon. In: Orvosi Hetilap. 2008 ; Vol. 149, No. 9. pp. 387-391.
@article{1c75e3ebca0643c68cf9c357d6859889,
title = "Szoliter hasny{\'a}lmirigy-{\'a}t{\"u}ltet{\'e}s elso esete Magyarorsz{\'a}gon",
abstract = "Simultaneous pancreas kidney (SPK) transplantation is the only routinely used therapeutic option which can provide insulin independence, euglycemia and good renal replacement for type I diabetes mellitus patients with end stage renal disease. Several patients have some complications of diabetes without renal failure. For these patients pancreas transplantation alone is a therapeutic option. The first pancreas transplantation alone was performed 6 years after the launch of our pancreas transplant program. The patient was a 40-years-old man. Enteric drainage was used with portal venous drainage. Anti IL-2. R antibody, daclizumab was given as prolonged induction therapy. In spite of the technical and immunological difficulties there were neither technical failures nor acute rejection. 3 years after the transplantation the patient has a good quality of life without insulin therapy with excellent renal function. Conclusion: PTA transplant is a routinely used therapeutic option with good survival rate and good quality of life for type I diabetes mellitus patients without end stage renal disease.",
keywords = "Porto-enteric drainage, PTA transplantation, Type I diabetes mellitus",
author = "P{\'e}ter Szak{\'a}ly and Kalm{\'a}r, {N{\'a}gy K{\'a}roly} and I. Wittmann",
year = "2008",
month = "3",
day = "2",
doi = "10.1556/OH.2008.28254",
language = "Hungarian",
volume = "149",
pages = "387--391",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "9",

}

TY - JOUR

T1 - Szoliter hasnyálmirigy-átültetés elso esete Magyarországon

AU - Szakály, Péter

AU - Kalmár, Nágy Károly

AU - Wittmann, I.

PY - 2008/3/2

Y1 - 2008/3/2

N2 - Simultaneous pancreas kidney (SPK) transplantation is the only routinely used therapeutic option which can provide insulin independence, euglycemia and good renal replacement for type I diabetes mellitus patients with end stage renal disease. Several patients have some complications of diabetes without renal failure. For these patients pancreas transplantation alone is a therapeutic option. The first pancreas transplantation alone was performed 6 years after the launch of our pancreas transplant program. The patient was a 40-years-old man. Enteric drainage was used with portal venous drainage. Anti IL-2. R antibody, daclizumab was given as prolonged induction therapy. In spite of the technical and immunological difficulties there were neither technical failures nor acute rejection. 3 years after the transplantation the patient has a good quality of life without insulin therapy with excellent renal function. Conclusion: PTA transplant is a routinely used therapeutic option with good survival rate and good quality of life for type I diabetes mellitus patients without end stage renal disease.

AB - Simultaneous pancreas kidney (SPK) transplantation is the only routinely used therapeutic option which can provide insulin independence, euglycemia and good renal replacement for type I diabetes mellitus patients with end stage renal disease. Several patients have some complications of diabetes without renal failure. For these patients pancreas transplantation alone is a therapeutic option. The first pancreas transplantation alone was performed 6 years after the launch of our pancreas transplant program. The patient was a 40-years-old man. Enteric drainage was used with portal venous drainage. Anti IL-2. R antibody, daclizumab was given as prolonged induction therapy. In spite of the technical and immunological difficulties there were neither technical failures nor acute rejection. 3 years after the transplantation the patient has a good quality of life without insulin therapy with excellent renal function. Conclusion: PTA transplant is a routinely used therapeutic option with good survival rate and good quality of life for type I diabetes mellitus patients without end stage renal disease.

KW - Porto-enteric drainage

KW - PTA transplantation

KW - Type I diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=40849111560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40849111560&partnerID=8YFLogxK

U2 - 10.1556/OH.2008.28254

DO - 10.1556/OH.2008.28254

M3 - Article

C2 - 18292032

AN - SCOPUS:40849111560

VL - 149

SP - 387

EP - 391

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 9

ER -